	The impact of perioperative oral care on postoperative infection in patients with esophageal cancer: a retrospective cohort study before and during COVID-19. Surg Today Kubo A, Fujita K, Tanaka S, Kimura Y, Wada N. PMID: 40085196 [PubMed - as supplied by publisher]
	Identification of immune subtypes associated with CD8+ T cell-related genes providing new treatment strategies of esophageal carcinoma. Front Immunol Wu Y, Lin C, Qian Y, Huang X, Xu Y, Li J, He Y, Xie C, Su H. PMID: 40083549 [PubMed - indexed for MEDLINE]
	Laparoscopic or open abdominal surgery with thoracotomy: future directions from the ROMIO trial in esophageal cancer. J Thorac Dis Kitagawa H, Seo S. PMID: 40083509 [PubMed]
	A real-world study of the efficacy of second-line treatment of unresectable hepatocellular carcinoma with esophagogastric varices after progression on first-line lenvatinib combined with PD-1 inhibitor. World J Surg Oncol Li S, Wen Q, Huang W, Qiu Z, Feng L, Yi F. PMID: 40082982 [PubMed - indexed for MEDLINE]
	Effect of computer aided detection system on esophageal neoplasm diagnosis in varied levels of endoscopists. NPJ Digit Med Li B, Du YY, Tan WM, He DL, Qi ZP, Yu HH, Shi Q, Ren Z, Cai MY, Yan B, Cai SL, Zhong YS. PMID: 40082585 [PubMed]
	Approaches for thoracoabdominal oesophagectomy for oesophageal cancer: a network meta-analysis - study protocol. BMJ Open Rebelo A, Friedrichs J, Grilli M, Vey J, Klose J, Merling M, Kleeff J, Ronellenfitsch U. PMID: 40082002 [PubMed - indexed for MEDLINE]
	Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer. Acta Oncol Skinnerup Byskov C, Mortensen HR, Biston MC, Broggi S, Bütof R, Canters R, Crehange G, Defraene G, Doyen J, Ehmsen ML, Fabiano S, Fracchiola F, Goudjil F, Haustermans K, Jensen SE, Jensen MF, Lecornu M, Makocki S, Mana AL, Martignano A, Meijers A, Mirandola A, Mitrea DA, Muijs CT, Møller DS, Nordsmark M, Orlandi E, Balermpas P, Populaire P, Scartoni D, Serrand J, Shamshad M, Slim N, Vanoni V, Vela A, Vidal M, Vilches-Freixas G, Weber D, Hoffmann L. PMID: 40079654 [PubMed - indexed for MEDLINE]
	Immune repertoire sequencing reveals differences in treatment response to camrelizumab plus platinum-based chemotherapy in advanced ESCC. Front Immunol Zhang X, Zhao W, Du Y, Su F, Zhang Y, Wang H, Li Y, Liu M, Gao Y, Cai L, Feng T, Wang M, Yao C, Xu N, Wang Y, Song G, Hu W, Zhao J. PMID: 40079001 [PubMed - indexed for MEDLINE]
	Prognostic value of c-MET in oesophageal squamous cell carcinoma: a study based on the mRNA expression in TCGA database and a meta-analysis. Front Med (Lausanne) Zhang Q, Li X, Li J, Zhang Z. PMID: 40078386 [PubMed]
	Current Advances in Immunotherapy Management of Esophageal Cancer. Cancers (Basel) Pyreddy S, Kim S, Miyamoto W, Talib Z, GnanaDev DA, Rahnemai-Azar AA. PMID: 40075698 [PubMed]
	A retrospective cohort study on radio/chemotherapy and survival following esophageal fistula in esophageal cancer patients with prior radiotherapy. BMC Cancer Xu W, Jiang H, Liu Y, Liu X, Jiang Y. PMID: 40075288 [PubMed - indexed for MEDLINE]
	First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 ExpressionÂ â‰¥Â 1%: A Retrospective Analysis of RATIONALE-305. Adv Ther Moehler M, Oh DY, Kato K, Arkenau T, Tabernero J, Lee KW, Rha SY, Hirano H, Spigel D, Yamaguchi K, Wyrwicz L, Disel U, Pazo-Cid RA, Fornaro L, Xu Y, Sheng T, Yang S, Kadva A, Cruz-Correa M, Xu RH. PMID: 40075025 [PubMed - as supplied by publisher]
	First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 ExpressionÂ â‰¥Â 1%: A Retrospective Analysis of RATIONALE-306. Adv Ther Xu J, Kato K, Hubner R, Park SR, Kojima T, Ishihara R, Wyrwicz L, Van Cutsem E, Jimenez-Fonseca P, Wu H, Wang L, Yan S, Shi J, Kadva A, Yoon HH. PMID: 40075024 [PubMed - as supplied by publisher]
	Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP). Clin Transl Oncol Alsina Maqueda M, Teijo Quintáns A, Cuatrecasas M, Fernández Aceñero MJ, Fernández Montes A, Gómez Martín C, Jiménez Fonseca P, Martínez Ciarpaglini C, Rivera Herrero F, Iglesias Coma M. PMID: 40072752 [PubMed - as supplied by publisher]
	Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics. BMC Cancer Yang J, Zhu Y, Zhou Y, Zhang J, Wei Y, Liu Y, Zhang B, Xie J, An X, Qi X, Yue Y, Zhang L, Zhang X, Fu Z, Liu K. PMID: 40069698 [PubMed - indexed for MEDLINE]
	FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer? Ann Nucl Med García Megías I, Almeida LS, Calapaquí Terán AK, Pabst KM, Herrmann K, Giammarile F, Delgado Bolton RC. PMID: 40069442 [PubMed - as supplied by publisher]
	Exosome-derived miR-148a-3p protect against tumor proliferation and metastasis of esophageal squamous carcinoma. Oncology Zhang J, Toyozum T, Kano M, Matsumoto Y, Otsuka R, Sekino N, Shiraishi T, Okada K, Kamata T, Iida S, Morishita H, Makino T, Nishioka Y, Yamada M, Uesato M, Hayano K, Nakano A, Matsubara H. PMID: 40068649 [PubMed - as supplied by publisher]
	Epidural analgesia during esophagectomy and esophageal cancer prognosis: A population-based nationwide study in Finland. Acta Anaesthesiol Scand Petäjäkangas PH, Helminen O, Helmiö M, Huhta H, Kallio R, Koivukangas V, Kokkola A, Laine S, Lietzen E, Meriläinen S, Pohjanen VM, Rantanen T, Ristimäki A, Räsänen JV, Saarnio J, Sihvo E, Toikkanen V, Tyrväinen T, Valtola A, Kauppila JH. PMID: 40066779 [PubMed - indexed for MEDLINE]
	Survival benefits of postoperative radiotherapy in esophageal cancer during the immunotherapy era:a retrospective cohort study based on the SEER database and a single-center registry in China. Front Immunol Zhang Q, Zhang T, Gu J, Zhang X, Mao Y, Zhu Y, Zhang J, Wang J, Chen S, Cao Y, Wang M, Wang C. PMID: 40066458 [PubMed - indexed for MEDLINE]
	Unveiling SSR4: a promising biomarker in esophageal squamous cell carcinoma. Front Immunol Zhang J, Jia F, Li C, Song S, Gong A. PMID: 40066443 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 35803

Page 1 of 1791



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy